After a dismal 2024, CVS Health (NYSE:CVS) could be starting to turn itself around. Some investors seem convinced, especially after the retail drugstore chain on Wednesday posted a big beat on ...

CVS (CVS) reported fourth quarter and full-year 2024 earnings Wednesday, beating Wall Street's expectations and sending its stock up 15% for the day. Full-year revenue came in at $372.8 billion, while ...